Litao Zhang | Akateeminen Kirjakauppa

Building upon the foundation of basics discussed in the previous edition, the Second Edition provides a more in-depth look at the latest methods and technologies of advanced drug screening, an essential function of drug discovery.

With extensively updated content and 21 new chapters, this text examines:







quality and efficiency of drug target validation and potential drug compound selection
reducing assay costs and improvement in assay technology
data quality improvement
trends in drug discovery
how drug screening can minimize adverse drug effects
recent advancements, including: high content screening; protein-protein interactions; high-throughput crystallization; lead optimization; chemoinformatics and microfluidics technologies; target validation by genomics, proteomics, and siRNA; structure-based drug design; automation; and medicinal chemistry